Key result
Multiple sclerosis linked to ~29-point higher autonomic disorder scores versus healthy controls.
Why the study?
Does heart rate variability and clinical scoring detect autonomic dysfunction in patients with multiple sclerosis compared to healthy controls?
Case-Control (n=70)
Does heart rate variability and clinical scoring detect autonomic dysfunction in patients with multiple sclerosis compared to healthy controls?
Clinical scoring and HRV analysis reveal significant autonomic dysfunction in patients with multiple sclerosis, suggesting utility for outpatient screening.
Answers are grounded in this paper and cite their sources.
Autonomic assessment may aid early MS diagnosis; hypothesis-generating and requires prospective validation before clinical adoption.
AIM: To optimize the early diagnosis of the autonomic dysfunction in patients with MS. MATERIAL AND METHODS: The main group consisted of 46 patients: 15 men and 31 women with MS (McDonald, 2005), the average age was 33.35±9.9 years, the average score of the Expanded disability scale (EDSS) was 2.8±1.17 points. The control group consisted of 24 healthy subjects matched by age and sex with the main group. A study of the autonomic nervous system was carried out using the Scheme for detection of signs of autonomic disorders (A.M. Vein, 1998) and analysis of heart rate variability (HRV) at rest and after active orthostatic test (AOT). RESULTS: Autonomic dysfunction was found in 73% of the patients. The overall score of the Scheme was significantly higher in MS patients (31.32±9.43 points) compared to the comparison group (2.36±4.39 points, p<0.05). According to HRV, the contribution of brainstem autonomic centers in the regulation of stress-response during AOP was significantly reduced (p<0.05) and was characterized by the lack of activation of the sympathetic division of the ANS. In patients with MS, cerebral influences were dominating on HRV baseline records, evaluated by the domination of the VLF component in the spectrum. During AOP, VLF was almost leveled in both groups, and the VLF changes in patients before and after the AOP reached statistical significance (p<0.05). CONCLUSION: The use of the Scheme is preferable in outpatient clinics to screen the large numbers of patients with MS, and then selected patients could be referred to the instrumental methods of investigation.
No takes yet. Share an insight, caveat, or question.
Рахматуллин et al. (2017) conducted a case-control in Multiple sclerosis (n=70). Multiple sclerosis vs. Healthy subjects was evaluated on Overall score of the Scheme for detection of signs of autonomic disorders (p=<0.05). Multiple sclerosis was associated with higher scores for autonomic disorders compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: